Please login to the form below
Astellas Pharma
This page shows the latest Astellas Pharma news and features for those working in and with pharma, biotech and healthcare.
China first market to approve AZ’s kidney drug roxadustat
AZ and FibroGen have rights to roxadustat in the US, China and other world markets, while Astellas Pharma will sell the drug in Europe and Japan.
Latest news
-
Astellas, Catalyst approvals set up record year for FDA approvals
The approvals of Astellas’ FLT3 inhibitor Xospata (gilteritinib) for acute myeloid leukaemia and Catalyst Pharmaceuticals’ Firdapse (amifampridine) for rare autoimmune disease Lambert-Eaton Myasthenic Syndrome (LEMS), already put the number for
-
Astellas makes another gene therapy play with Juventas deal
Astellas says that faecal incontinence is widespread and has no effective treatments, severely impacting the quality of life of patients with the disorder. ... We are excited to partner with Astellas to advance the programme for treatment of patients
-
Daily Brief: Orchard raises $150m, Astellas swoops for early-stage gene company, Amicus gets FDA Fabry approval
Astellas acquires UK gene therapy company Quethera. Japan’s Astellas Pharma is to acquire UK-based gene therapy company Quethera for $85m. ... Yasukawa, Ph.D., who took over as president and CEO of Astellas in February.
-
Daily Brief: Immunotherapy combos dominate ASCO, Pharma's Brexit warning, Big data and prostate cancer
The European Union’s Innovative Medicines Initiative (IMI) has been around 10 years, and has produced some major research collaborations between pharma, biotech and academics. ... Alex Asiimwe, Director and Global TA head, epidemiology, Bayer. The
-
J&J’s Erleada first US drug for non-metastatic prostate cancer
It also gives J&J a leg-up in what looks set to be a big market tussle with Pfizer and Astellas and their Xtandi (enzalutamide) product, which has also been ... J&J acquired Erleada when it took over Aragon Pharma in 2013 in a deal valued at $1bn.
More from news
Approximately 1 fully matching, plus 123 partially matching documents found.
Latest Intelligence
-
The good, the bad and the ugly
AstraZeneca, Takeda, Astellas Pharma, Novo Nordisk and Recordati take up the final five positions, though only two - Takeda (3.9%) and Astellas (9.3%) - recorded growth. ... The data this article was based on is available in full online:
-
Case study: Action on Fistula
Client:Astellas Pharma EMEA Limited. Agency:Forster Communications. Campaign:Action on Fistula. Timescale:. Action on Fistula, launched in May 2014, is an innovative partnership between Astellas Pharma EMEA Limited and the ... Astellas’ investment in
-
Japanese pharma pulls no punches with post-Brexit UK
Yasuo Sakae, vice president of corporate strategy and planning at Astellas Pharma Europe, told PME that the company’s regulatory team for the Europe, Middle East and Africa (EMEA) region is ... globally, as well as the presence of world-class
-
Deal Watch July 2016
$225m. $36m. LEO Pharma. AstraZeneca. $1, 115m. $115m. Astellas. Cytokinetics. $100m. ... In at numbers 2, 3 and 4 are the LEO-AstraZeneca deal with an upfront of $115m, Astellas-Cytokinetics at $95m and Almirall-Sun Pharma at $50m (see below).
-
Astellas: Ten years young
s first decade of operations and hear from two of its senior executives on where Astellas is heading. ... In Europe sales rose 18.5% in 2014 and the region has been of increasing importance to Astellas.
More from intelligence
Approximately 1 fully matching, plus 20 partially matching documents found.
Latest appointments
-
Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
Taylor joins the agency from Astellas, where she was senior director of corporate communications, EMEA. ... run those very departments in global pharma companies and we therefore completely understand the challenges they face.
-
Astellas strengthens US and Canadian leadership team
Astellas has promoted Steve Sabus (pictured right) to general manager of Astellas Pharma Canada, effective from 1 April this year. ... needs.”. Sabus joined Astellas in 2007 and has over 25 years’ experience in the pharmaceutical industry.
-
Astellas promotes Anthony Fiordaliso to VP, Americas finance
He first joined the pharma firm in 2010 from Schering-Plough. Astellas has promoted Anthony Fiodaliso to VP, Americas finance to oversee areas such as managerial reporting and budgeting, financial planning ... In his new role Fiordaliso will report
-
Dendreon appoints new R&D lead
Joining from Astellas Pharma, Dr Brown most recently served as senior medical director of oncology, where he led US medical strategy for the prostate cancer drug Xtandi (enzalutamide).
-
Astellas appoints new senior VP
Astellas.”. “I’m confident she will make an immediate and positive impact on both the team in the Americas, as well as the patients and partners we serve.”. ... She has also received multiple awards for leadership and innovation through her career
More from appointments
Approximately 0 fully matching, plus 29 partially matching documents found.
Latest from PMHub
-
emotive boosts health economics and outcomes research team
Since joining emotive in May 2014, he has played a key role in the delivery of a range of creative health economics solutions for a variety of pharma clients, across different ... major pharma clients, including Bayer and Astellas.
-
How to integrate data to drive sales
Inspired by a recent Agnitio roundtable discussion with Allergan, Ariad Pharmaceuticals, Astellas and Ipsen Pharma. As the number of our digital channels and tools continually expand, there are many opportunities to
-
World’s Largest Pharmaceutical Summit Brings Latest Innovations To Light In New Award Ceremony
Astellas Pharma, Bayer, Pfizer and MSD are amongst the shortlisted companies who will join an exclusive celebration to recognise what really matters when it comes to supporting real patient outcomes. ... Customer Innovator Award and Lifetime Value
More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Salary TBC
- Medical Writer/ Senior Medical Writer opportunities – Macclesfie...
-
competitive salary and benefits package
Subscribe to our email news alerts
PMHub
OUTiCO
Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...
Latest intelligence
- Women Leaders in UK Healthcare: Liz Henderson
- Merck UK & Ireland’s MD on her ‘non-linear’ career and the importance of mentoring...
- Webinar: Usability and UX: You’ve been asked to test...What next?
- Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
- Event: EphMRA Annual Conference
- We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Quick links
Infographics
